BioSyent (RX) Stock Chart & Stock Price History → Shocking $16T Elon Musk Crypto Leak (From Crypto 101 Media) (Ad) Free RX Stock Alerts C$9.18 +0.03 (+0.33%) (As of 06/7/2024 05:18 PM ET) Add Compare Share Share ChartStock AnalysisChartEarningsHeadlinesInsider TradesStock AnalysisChartEarningsHeadlinesInsider Trades BioSyent Stock Price Performance5 Day Performance+0.55%1 Month Performance+6.87%3 Month Performance+5.88%6 Month Performance+8.00%Year-To-Date Performance-0.43%1 Year Performance+24.90% Receive RX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BioSyent and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. RX Stock Chart for Sunday, June, 9, 2024 RX Chart by TradingView BioSyent Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/07/2024C$9.15C$9.18+0.33%C$9.19C$9.14800 shsC$106.40 million06/06/2024C$9.30C$9.15-1.61%C$9.15C$9.15810 shsC$106.05 million06/05/2024C$9.13C$9.30+1.86%C$9.30C$9.301,735 shsC$107.79 million06/04/2024C$9.10C$9.13+0.33%C$9.13C$9.13455 shsC$105.82 million06/03/2024C$9.05C$9.10+0.55%C$9.21C$9.0514,573 shsC$105.47 million05/31/2024C$9.10C$9.05-0.55%C$9.10C$9.0520,401 shsC$104.89 million Get the Latest News and Ratings for RX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BioSyent and its competitors with MarketBeat's FREE daily newsletter. 05/30/2024C$9.32C$9.10-2.36%C$9.15C$8.9723,235 shsC$105.47 million05/29/2024C$9.25C$9.32+0.76%C$9.32C$8.9911,950 shsC$108.02 million05/28/2024C$9.10C$9.25+1.65%C$9.25C$9.006,485 shsC$107.21 million05/27/2024C$9.15C$9.10-0.55%C$9.15C$9.1010,200 shsC$105.47 million05/24/2024C$9.19C$9.15-0.44%C$9.19C$9.0011,929 shsC$106.05 million05/23/2024C$9.00C$9.19+2.11%C$9.20C$8.923,111 shsC$106.51 million05/22/2024C$9.00C$9.00C$9.07C$8.9524,540 shsC$104.31 million05/21/2024C$9.00C$9.00C$9.00C$8.8827,324 shsC$104.31 million05/20/2024C$9.00C$9.00C$9.10C$8.8152,002 shsC$104.31 million05/17/2024C$8.50C$9.00+5.88%C$9.10C$8.8152,002 shsC$104.49 million05/16/2024C$8.24C$8.50+3.16%C$8.72C$8.503,879 shsC$98.69 million05/15/2024C$8.37C$8.24-1.55%C$8.24C$8.24380 shsC$95.67 million05/14/2024C$8.50C$8.37-1.53%C$8.51C$8.344,795 shsC$97.18 million05/13/2024C$8.50C$8.50C$8.51C$8.501,540 shsC$98.69 million05/10/2024C$8.59C$8.50-1.05%C$8.60C$8.502,200 shsC$98.69 million05/09/2024C$8.51C$8.59+0.94%C$8.61C$8.592,600 shsC$99.73 million05/08/2024C$8.65C$8.51-1.62%C$8.60C$8.511,207 shsC$98.80 million05/07/2024C$8.51C$8.65+1.65%C$8.68C$8.651,100 shsC$100.43 million05/06/2024C$8.65C$8.51-1.62%C$8.62C$8.512,432 shsC$98.80 million05/03/2024C$8.69C$8.65-0.46%C$8.80C$8.659,142 shsC$100.43 million05/02/2024C$8.69C$8.69C$8.69C$8.603,000 shsC$100.89 million05/01/2024C$8.60C$8.69+1.05%C$8.69C$8.65400 shsC$100.89 million04/30/2024C$8.63C$8.60-0.35%C$8.69C$8.60504 shsC$99.85 million04/29/2024C$8.51C$8.63+1.41%C$8.63C$8.4316,229 shsC$100.19 million04/26/2024C$8.51C$8.51C$8.69C$8.453,825 shsC$98.80 million04/25/2024C$8.40C$8.51+1.31%C$8.51C$8.507,093 shsC$98.80 million04/24/2024C$8.40C$8.40C$8.61C$8.4065,245 shsC$97.52 million04/23/2024C$8.40C$8.40C$8.50C$8.402,777 shsC$97.52 million04/22/2024C$8.50C$8.40-1.18%C$8.60C$8.403,736 shsC$97.52 million04/19/2024C$8.45C$8.50+0.59%C$8.60C$8.502,700 shsC$98.69 million04/18/2024C$8.55C$8.45-1.17%C$8.53C$8.453,772 shsC$98.10 million04/17/2024C$8.55C$8.55C$8.55C$8.504,750 shsC$99.27 million04/16/2024C$8.64C$8.55-1.04%C$8.59C$8.521,780 shsC$99.27 million04/15/2024C$8.65C$8.64-0.12%C$8.64C$8.551,400 shsC$100.31 millionTime is Running Out - June 25th Deadline Approaching! (Ad)Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.That will slam shut June 25.04/12/2024C$8.60C$8.65+0.58%C$8.65C$8.622,200 shsC$100.43 million04/11/2024C$8.58C$8.60+0.23%C$8.60C$8.583,260 shsC$99.85 million04/10/2024C$8.60C$8.58-0.23%C$8.60C$8.585,900 shsC$99.61 million04/09/2024C$8.65C$8.60-0.58%C$8.65C$8.5642,453 shsC$99.85 million04/08/2024C$8.62C$8.65+0.35%C$8.75C$8.632,772 shsC$100.43 million04/05/2024C$8.65C$8.62-0.35%C$8.65C$8.584,007 shsC$100.08 million04/04/2024C$8.60C$8.65+0.58%C$8.65C$8.606,119 shsC$100.43 million04/03/2024C$8.65C$8.60-0.58%C$8.64C$8.562,195 shsC$99.85 million04/02/2024C$8.69C$8.65-0.46%C$8.65C$8.647,056 shsC$100.43 million04/01/2024C$8.70C$8.69-0.11%C$8.70C$8.654,625 shsC$100.89 million03/29/2024C$8.70C$8.70C$8.70C$8.673,178 shsC$101.01 million03/28/2024C$8.70C$8.70C$8.70C$8.673,178 shsC$101.01 million03/27/2024C$8.69C$8.70+0.12%C$8.70C$8.642,202 shsC$101.01 million03/26/2024C$8.70C$8.69-0.11%C$8.70C$8.671,799 shsC$100.89 million03/25/2024C$8.63C$8.70+0.81%C$8.70C$8.69395 shsC$101.01 million03/22/2024C$8.70C$8.63-0.80%C$8.70C$8.618,165 shsC$100.19 million03/21/2024C$8.59C$8.70+1.28%C$8.70C$8.642,810 shsC$101.01 million03/20/2024C$8.50C$8.59+1.06%C$8.62C$8.586,436 shsC$99.73 million03/19/2024C$8.59C$8.50-1.05%C$8.64C$8.503,818 shsC$98.69 million03/18/2024C$8.51C$8.59+0.94%C$8.66C$8.4122,134 shsC$99.73 million03/15/2024C$8.61C$8.51-1.16%C$8.60C$8.501,745 shsC$98.80 million03/14/2024C$8.65C$8.61-0.46%C$8.79C$8.6111,195 shsC$100.31 million03/13/2024C$8.65C$8.65C$8.80C$8.656,000 shsC$100.77 million03/12/2024C$8.60C$8.65+0.58%C$8.67C$8.653,100 shsC$100.77 million03/11/2024C$8.67C$8.60-0.81%C$8.67C$8.604,374 shsC$100.19 million03/08/2024C$8.78C$8.67-1.25%C$8.68C$8.672,560 shsC$101.01 million Related Companies: Organigram Stock Price Chart Cardiol Therapeutics Stock Price Chart Cipher Pharmaceuticals Stock Price Chart HLS Therapeutics Stock Price Chart Decibel Cannabis Stock Price Chart Charlotte's Web Stock Price Chart MediPharm Labs Stock Price Chart Medicure Stock Price Chart Indiva Stock Price Chart Willow Biosciences Stock Price Chart Receive RX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for BioSyent and its competitors with MarketBeat's FREE daily newsletter. This page (CVE:RX) was last updated on 6/9/2024 by MarketBeat.com Staff From Our PartnersCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredTime is Running Out - June 25th Deadline Approaching!Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRIL...Paradigm Press | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredUrgent alert: open this for a huge profit potentialThis groundbreaking technology that Tim calls “Inception” isn’t being talked about anywhere… not on Fox, Yahoo...Timothy Sykes | SponsoredWho are Nvidia’s Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioSyent Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioSyent With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.